A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies

The primary molecular endpoint for many Duchenne muscular dystrophy (DMD) clinical trials is the induction, or increase in production, of dystrophin protein in striated muscle. For accurate endpoint analysis, it is essential to have reliable, robust and objective quantification methodologies capable...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaglioni, Dominic, Ellis, Matthew, Catapano, Francesco, Torelli, Silvia, Chambers, Darren, Feng, Lucy, Sewry, Caroline, Morgan, Jennifer, Muntoni, Francesco, Phadke, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165405/
https://www.ncbi.nlm.nih.gov/pubmed/32303261
http://dx.doi.org/10.1186/s40478-020-00918-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165405/
https://www.ncbi.nlm.nih.gov/pubmed/32303261
http://dx.doi.org/10.1186/s40478-020-00918-5

Ejemplares similares